Tag: #RenalTransplant
-
Daily Tacrolimus Dosing Reduces PostTransplant Risks Insights from a Renal Transplant Study
Introduction Improving medication adherence in renal transplant patients is crucial to enhancing long-term graft survival. A recent study sheds light on the comparative benefits of once-daily tacrolimus (extended-release) over conventional twice-daily regimens. Conducted at Suguna Hospital, Bangalore, this research highlights how simplified dosing can significantly reduce infection rates and post-transplant diabetes mellitus (PTDM) among kidney…
-
Tacrolimus Formulations in Renal Transplant Recipients Which One is More Effectiv
Introduction Tacrolimus is a crucial immunosuppressant used to prevent organ rejection in renal transplant recipients. However, maintaining therapeutic levels is challenging due to individual patient variations. A recent study compared three tacrolimus formulations—Immediate-Release (TAC-IR), Extended-Release Capsules (TAC-XL), and Extended-Release Tablets (TAC-XR)—to evaluate their effectiveness in keeping drug levels within the therapeutic range (TTR). Visit Horizon…
-
Advancements in Positive Crossmatch Renal Transplantation Three Year Outcomes After Desensitization
Introduction Renal transplantation remains the gold standard for treating end-stage renal disease (ESRD), offering superior survival benefits compared to dialysis. However, patients with a positive crossmatch (PXM) face significant challenges due to donor-specific antibodies (DSA), increasing the risk of rejection. Recent advancements in desensitization protocols have enabled successful kidney transplants in sensitized patients. A study…
Heighten Science Publications Inc. 